Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare neoplasm currently classified among acute myeloid leukemias (AMLs) in the last edition of the WHO classification [1]. BPDCN is thought...
No takes yet. Share an insight, caveat, or question.
Piccaluga et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: